Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Bejon

Showing results (251-260 of 276) with videos related to

Pageof 28
Sort By:
The New England Journal of Medicine|February 19, 2025
Low-Dose Yellow Fever Vaccine in Adults in AfricaDerick Kimathi, Aitana Juan-Giner, Ndeye S Bob, et al.
Nature Medicine|January 6, 2026
Malaria vaccine protection against intradermal or venous parasites: a randomized phase 2b human challenge trialMelissa C Kapulu, Francesca Orenge, Domtila Kimani, et al.
Wellcome Open Research|June 20, 2025
A pragmatic randomized controlled trial of standard care versus corticosteroids plus standard care for treatment of pneumonia in adults admitted to Kenyan hospitals (SONIA)Ruth Lucinde, Abdirahman Abdi, Benedict Orindi, et al.
The Lancet. Microbe|November 10, 2024
Identification of complex Plasmodium falciparum genetic backgrounds circulating in Africa: a multicountry genomic epidemiology analysisOlivo Miotto, Alfred Amambua-Ngwa, Lucas N Amenga-Etego, et al.
Influenza and Other Respiratory Viruses|September 26, 2023
SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February-December 2022E Wangeci Kagucia, Abdhala K Ziraba, James Nyagwange, et al.
Science (New York, N.Y.)|November 12, 2020
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donorsSophie Uyoga, Ifedayo M O Adetifa, Henry K Karanja, et al.
Lancet (London, England)|January 16, 2026
Low-dose yellow fever vaccination in infants: a randomised, double-blind, non-inferiority trialDerick Kimathi, Aitana Juan-Giner, Ndeye S Bob, et al.
Viruses|June 24, 2022
Genomic Epidemiology of SARS-CoV-2 in Seychelles, 2020-2021John Mwita Morobe, Brigitte Pool, Lina Marie, et al.
Wellcome Open Research|February 12, 2021
Pooled testing conserves SARS-CoV-2 laboratory resources and improves test turn-around time: experience on the Kenyan CoastCharles N Agoti, Martin Mutunga, Arnold W Lambisia, et al.
BMC Medicine|January 20, 2018
Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria - a proposed model-derived age-based regimen for sub-Saharan AfricaW Robert Taylor, Htee Khu Naw, Kathryn Maitland, et al.
Pageof 28

Showing results (251-260 of 276) with videos related to

Sort By:
Pageof 28
The New England Journal of Medicine|February 19, 2025
Low-Dose Yellow Fever Vaccine in Adults in AfricaDerick Kimathi, Aitana Juan-Giner, Ndeye S Bob, et al.
Nature Medicine|January 6, 2026
Malaria vaccine protection against intradermal or venous parasites: a randomized phase 2b human challenge trialMelissa C Kapulu, Francesca Orenge, Domtila Kimani, et al.
Wellcome Open Research|June 20, 2025
A pragmatic randomized controlled trial of standard care versus corticosteroids plus standard care for treatment of pneumonia in adults admitted to Kenyan hospitals (SONIA)Ruth Lucinde, Abdirahman Abdi, Benedict Orindi, et al.
The Lancet. Microbe|November 10, 2024
Identification of complex Plasmodium falciparum genetic backgrounds circulating in Africa: a multicountry genomic epidemiology analysisOlivo Miotto, Alfred Amambua-Ngwa, Lucas N Amenga-Etego, et al.
Influenza and Other Respiratory Viruses|September 26, 2023
SARS-CoV-2 seroprevalence and implications for population immunity: Evidence from two Health and Demographic Surveillance System sites in Kenya, February-December 2022E Wangeci Kagucia, Abdhala K Ziraba, James Nyagwange, et al.
Science (New York, N.Y.)|November 12, 2020
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donorsSophie Uyoga, Ifedayo M O Adetifa, Henry K Karanja, et al.
Lancet (London, England)|January 16, 2026
Low-dose yellow fever vaccination in infants: a randomised, double-blind, non-inferiority trialDerick Kimathi, Aitana Juan-Giner, Ndeye S Bob, et al.
Viruses|June 24, 2022
Genomic Epidemiology of SARS-CoV-2 in Seychelles, 2020-2021John Mwita Morobe, Brigitte Pool, Lina Marie, et al.
Wellcome Open Research|February 12, 2021
Pooled testing conserves SARS-CoV-2 laboratory resources and improves test turn-around time: experience on the Kenyan CoastCharles N Agoti, Martin Mutunga, Arnold W Lambisia, et al.
BMC Medicine|January 20, 2018
Single low-dose primaquine for blocking transmission of Plasmodium falciparum malaria - a proposed model-derived age-based regimen for sub-Saharan AfricaW Robert Taylor, Htee Khu Naw, Kathryn Maitland, et al.
Pageof 28